• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神疾病、高泌乳素血症的治疗及多巴胺激动剂

Treatments of psychiatric disorders, hyperprolactinemia and dopamine agonists.

作者信息

Chanson Philippe

机构信息

Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, 94275 Le Kremlin-Bicêtre, France.

出版信息

Best Pract Res Clin Endocrinol Metab. 2022 Dec;36(6):101711. doi: 10.1016/j.beem.2022.101711. Epub 2022 Oct 12.

DOI:10.1016/j.beem.2022.101711
PMID:36280567
Abstract

While the prevalence of hyperprolactinemia under antidepressants is very low, its prevalence under antipsychotics, particularly of the first generation, is high. Antipsychotics act by blocking dopamine activity at the level of the dopamine type 2 receptor (D2R). When prolactin levels exceed 80-100 ng/ml, a pituitary adenoma must be ruled out by MRI. Treatment of hyperprolactinemia is necessary only in cases with clinical symptoms of hypogonadism. Three treatment options are possible: switch to a less hyperprolactinemic antipsychotic, sex steroid supplementation or dopamine agonist (which normalizes prolactin levels in only half of cases). Fortunately, psychotic exacerbation due to the opposing effects of antipsychotics and dopamine agonists on the D2R seems very rare. When a patient presents with a macroprolactinoma, particularly with optic chiasm compression, surgery or dopamine agonists may be proposed. The agonists are effective in reducing tumor mass and improving visual defects in the majority of patients but rarely normalize prolactin levels.

摘要

虽然抗抑郁药导致高催乳素血症的发生率很低,但抗精神病药,尤其是第一代抗精神病药导致的高催乳素血症发生率很高。抗精神病药通过阻断2型多巴胺受体(D2R)水平的多巴胺活性发挥作用。当催乳素水平超过80 - 100 ng/ml时,必须通过磁共振成像(MRI)排除垂体腺瘤。仅在出现性腺功能减退临床症状的情况下才需要治疗高催乳素血症。有三种治疗选择:换用催乳素血症较轻的抗精神病药、补充性类固醇或使用多巴胺激动剂(仅半数病例可使催乳素水平恢复正常)。幸运的是,抗精神病药和多巴胺激动剂对D2R的相反作用导致精神病恶化的情况似乎非常罕见。当患者出现大催乳素瘤,尤其是伴有视交叉受压时,可考虑手术或使用多巴胺激动剂。激动剂在大多数患者中可有效减小肿瘤体积并改善视觉缺陷,但很少能使催乳素水平恢复正常。

相似文献

1
Treatments of psychiatric disorders, hyperprolactinemia and dopamine agonists.精神疾病、高泌乳素血症的治疗及多巴胺激动剂
Best Pract Res Clin Endocrinol Metab. 2022 Dec;36(6):101711. doi: 10.1016/j.beem.2022.101711. Epub 2022 Oct 12.
2
Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma.抗精神病药物治疗的伴有大腺瘤的患者中多巴胺激动剂的疗效和安全性。
Eur J Endocrinol. 2020 Aug 1;183(2):221-231. doi: 10.1530/EJE-20-0125.
3
Dopamine agonists and antipsychotics.多巴胺激动剂和抗精神病药物。
Eur J Endocrinol. 2020 Sep;183(3):C11-C13. doi: 10.1530/EJE-20-0607.
4
Hyperprolactinemia and prolactinoma.高催乳素血症与催乳素瘤。
Handb Clin Neurol. 2014;124:185-95. doi: 10.1016/B978-0-444-59602-4.00013-7.
5
Drug treatment of hyperprolactinemia.高催乳素血症的药物治疗。
Ann Endocrinol (Paris). 2007 Jun;68(2-3):113-7. doi: 10.1016/j.ando.2007.03.003. Epub 2007 May 29.
6
The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.阿立哌唑和喹高利特(一种多巴胺激动剂)对有症状的垂体泌乳素瘤和慢性精神病患者的疗效。
Gen Hosp Psychiatry. 2012 Mar-Apr;34(2):209.e1-3. doi: 10.1016/j.genhosppsych.2011.07.004. Epub 2011 Aug 26.
7
[Current diagnosis and treatment of hyperprolactinemia].[高催乳素血症的当前诊断与治疗]
Rev Med Inst Mex Seguro Soc. 2016 Jan-Feb;54(1):111-21.
8
[Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].[抗精神病药物所致高催乳素血症:病理生理学、临床特征及指导]
Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5.
9
Hyperprolactinemia: pathophysiology and management.高催乳素血症:病理生理学与管理
Treat Endocrinol. 2003;2(1):23-32. doi: 10.2165/00024677-200302010-00003.
10
Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.泌乳素瘤与高泌乳素血症无功能性腺瘤的鉴别诊断。
Endocrine. 2010 Feb;37(1):140-7. doi: 10.1007/s12020-009-9279-7. Epub 2009 Nov 14.

引用本文的文献

1
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.催乳素分泌型垂体腺瘤的诊断和治疗:垂体学会国际共识声明。
Nat Rev Endocrinol. 2023 Dec;19(12):722-740. doi: 10.1038/s41574-023-00886-5. Epub 2023 Sep 5.